Simon Ekman
Medical Unit Head And Neck
Stockholm, AB, Sweden
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.
Journal: Frontiers in immunology
Published: June 09, 2026
Correction: Ekman et al. Synthesis, Characterization, and Adsorption Properties of Nitrogen-Doped Nanoporous Biochar: Efficient Removal of Reactive Orange 16 Dye and Colorful Effluents. Nanomaterials 2023, 13, 2045.
Journal: Nanomaterials (Basel, Switzerland)
Published: May 25, 2026
Complications following small-molecule inhibitors for non-small cell lung cancer.
Journal: Expert review of anticancer therapy
Published: May 10, 2026
Prognostic impact of the 9th vs 8th TNM classification in small-cell lung cancer. a population-based study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 12, 2026
Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field.
Journal: Journal of internal medicine
Published: February 14, 2026
Feasibility of lung cancer screening in low-risk populations of the Nordic countries.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 30, 2026
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 10, 2025
The brain-lung immunotherapy prognostic (BLIP) Score: a novel robust tool for prognostication in non-small cell lung cancer patients with brain metastases.
Journal: British journal of cancer
Published: October 28, 2025
Risk Factors for Developing Venous Thromboembolism in Patients With Advanced ALK-Rearranged NSCLC.
Journal: JTO clinical and research reports
Published: October 07, 2025
An observational study to identify selection criteria for initiation of different first line treatment options in patients with non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: September 18, 2025
Last Updated: 09/26/2026